EMEA-002780-PIP02-20-M02 - paediatric investigation plan
Multivalent pneumococcal polysaccharide conjugate to carrier protein (PCV21)
PIPHuman
Key facts
- Active Substance
- Multivalent pneumococcal polysaccharide conjugate to carrier protein (PCV21)
- Therapeutic area
- Infections and infestations
- Decision number
- P/0288/2024
- PIP number
- EMEA-002780-PIP02-20-M02
- Pharmaceutical form(s)
- Suspension for injection
- Condition(s) / indication(s)
- Prevention of disease caused by Streptococcus pneumoniae
- Route(s) of administration
- Intramuscular use
- Contact for public enquiries
Sanofi Winthrop Industrie
E-mail: contact-us@sanofi.com
Tel: +33 1 69 74 56 95- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date